Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at University of Gondar Hospital, Northwest Ethiopia

BMC Hematology

Volumn 16, Issue 1, 2016, Pages

  Kassa, Eyuel ^a   Enawgaw, Bamlaku ^a   Gelaw, Aschalew ^a   Gelaw, Baye ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

Anti TB drugs; Haematological profile; Intensive phase; Tuberculosis

Indexed keywords

HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; AUTOMATION; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DRUG EFFECT; ETHIOPIA; FEMALE; HEMATOCRIT; HEMATOLOGIC DISEASE; HEMATOLOGICAL PARAMETERS; HEMATOLOGY ANALYZER; HUMAN; HUMAN CELL; INTENSIVE CARE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOPENIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PLATELET DISTRIBUTION WIDTH; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUESTIONNAIRE; RED CELL DISTRIBUTION WIDTH; SCHOOL CHILD; SPUTUM SMEAR; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOSIS; UNIVERSITY HOSPITAL; VENOUS BLOOD;

EID: 85011374976     PISSN: None     EISSN: 20521839     Source Type: Journal    
DOI: 10.1186/s12878-015-0037-1     Document Type: Article

References (45)

1. World Health Organization. Global tuberculosis control: WHO report 2010. Geneva, Switzerland: WHO; 2010.
2. Federal Ministry of Health Ethiopia. Tuberculosis, leprosy and TB/HIV prevention and control programme manual. 4th ed. Addis Ababa: MOH; 2008.
3. World Health Organization. WHO declares TB an emergency in Africa. Call for urgent and extraordinary actions to halt a worsening epidemic. Geneva, Switzerland: WHO; 2005.
4. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2008; No. 393. Geneva, Switzerland: WHO; 2008.
5. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva, Switzerland: WHO; 2007.
6. Loulergue P, Mir O, Dhote R. Pure red blood cell aplasia and isoniazid use. Emerg Infect Dis. 2007;13(9):1427.
7. Agarwal AK, Chugh IM, Panjabi C, Dewan S, Shah A. Asymptomatic aplasticanaemia in a patient receiving anti-tuberculosis treatment. Indian J Tuberc. 2001;48(2):97–100.
8. Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv. Hematol. 2009;2009:495863. doi:10.1155/2009/495863.
9. Whitfield CL. Hematologic abnormalities in tuberculous patients. Arch Intern Med. 1970;126(4):698.
10. Nagayama N, Shishido Y, Masuda K, Baba M, Tamura A, Nagai H, et al. Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid. Kekkaku: [Tuberculosis]. 2004;79(5):341–8.
11. Muzaffar TM, Shaifuzain AR, Imran Y, Haslina MN. Hematological changes in tuberculous spondylitis patients at the Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health. 2008;39(4):686–9.
12. Yaranal PJ, Umashankar T, Harish SG. Hematological profile in pulmonary tuberculosis. Int J Health Rehabil Sci. 2013;2(1):50–5.
13. Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med. 1990;89(3):291–6.
14. Olaniyi J, Aken'Ova Y. Haematological profile of patients with pulmonary tuberculosis in Ibadan, Nigeria. Afr J Med Med Sci. 2003;32(3):239–42.
15. Koju D, Rao B, Shrestha B, Shakya R, Makaju R. Occurrence of side effects from anti-tuberculosis drugs in urban Nepalese population under DOTS treatment. Kathmandu University J Sci Eng Technol. 2005;1(1):1–2.
16. Oyer RA, Schlossberg D. Hematologic changes in tuberculosis. In: Schlossberg D, editor. Tuberculosis & Nontuberculous Mycobacterial infections. 5th ed. New Delhi: Tata McGraw-Hill; 2007. pp. 357–64.
17. Tsegaye A, Messele T, Tilahun T, Hailu E, Sahlu T, Doorly R, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol. 1999;6(3):410–4.
18. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002;16(2):87–96.
19. Baynes R, Flax H, Bothwell T, Bezwoda W, Atkinson P, Mendelow B. Red blood cell distribution width in the anemia secondary to tuberculosis. Am J Clin Pathol. 1986;85(2):226–9.
20. Lee SW, Kang Y, Yoon YS, Um S-W, Lee SM, Yoo C-G, et al. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci. 2006;21(6):1028–32.
21. Berkowitz FE. Hemolysis and infection: categories and mechanisms of their interrelationship. Review of Infectious Diseases. 1991;13(6):1151–62.
22. Means Jr RT. Recent developments in the anemia of chronic disease. Curr Hematol Rep. 2003;2(2):116–21.
23. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig. 2004;113(9):1271.
24. Singh K, Ahulwalia G, Sharma S, Saxena R, Chaudhary V, Anant M. Significance of haematological manifestations in patients with tuberculosis. J Assoc Physicians India. 2001;49(788):790–4.
25. Bhatt V, Saleem A. Drug-induced neutropenia–pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34(2):131–7.
26. Nagu TJ, Spiegelman D, Hertzmark E, Aboud S, Makani J, Matee MI, et al. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PLoS One. 2014;9(3), e91229.
27. Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both drug-dependent and drug-specific antibodies. Blood. 2006;108(3):922–7.
28. Von Drygalski A, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med. 2007; 356(9):904–10.
29. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357(6):580–7.
30. Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am. 2007;21(4):685–96.
31. Baynes R, Flax H, Bothwell T, Bezwoda W, MacPhail A, Atkinson P, et al. Haematological and iron-related measurements in active pulmonary tuberculosis. Scand J Haematol. 1986;36(3):280–7.
32. Morris CD, Bird AR, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. QJM. 1989;73(3):1151–9.
33. Lombard E, Mansvelt E. Haematological changes associated with miliary tuberculosis of the bone marrow. Tuber Lung Dis. 1993;74(2):131–5.
34. Dosumu E. Pattern of some haematological indices in newly diagnosed pulmonary tuberculosis cases in Iwo, Nigeria: diagnostic and therapeutic implications. Niger J Med. 2000;10(1):18–20.
35. Vajpayee N, Graham S, Bem S. Basic examination of blood and bone marrow. In: McPherson RA, Pincus MR, editors. Henry's clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia, PA: Elsevier/ Saunders; 2011. p. 30.
36. Subhashree A, Parameaswari P, Shanthi B, Revathy C, Parijatham B. The reference intervals for the haematological parameters in healthy adult population of chennai, southern India. J Clin Diagn Res. 2012;6(10):1675–80.
37. Pascual-Figal DA, Bonaque JC, Manzano-Fernández S, Fernández A, Garrido IP, Pastor-Perez F, et al. Red blood cell distribution width predicts newonset anemia in heart failure patients. Int J Cardiol. 2012;160(3):196–200.
38. Bessman J, Gilmer Jr P, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80(3):322–6.
39. Abdelrahman EG, Gasim GI, Musa IR, Elbashir LM, Adam I. Red blood cell distribution width and iron deficiency anemia among pregnant Sudanese women. Diagn Pathol. 2012;7(168):1596–7.
40. Rieder HL. Intervention for tuberculosis control and elimination. Paris, International Union Against Tuberculosis and Lung Disease, 2002:pp.554. https://books.google.com.et/books?isbn=1444113542
41. Osselaer J-C, Jamart J, Scheiff J-M. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem. 1997;43(6):1072–6.
42. Tozkoparan E, Deniz O, Ucar E, Bilgic H, Ekiz K. Changes in platelet count and indices in pulmonary tuberculosis. Clin Chem Lab Med. 2007;45(8): 1009–13.
43. Yakar F, Yildiz N, Yakar A, Kılıçaslan Z. Isoniazid-and rifampicin-induced thrombocytopenia. Multidiscip Respir Med. 2013;8(1):13.
44. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998;129(11):886–90.
45. Sahin F, Yazar E, Yildiz P. Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis. Multidiscip Respir Med. 2012;7(1):38.